Daniel Rippy | Executive Director - Business Development
UMASS Chan Medical School

Dan Rippy is Executive Director of Business Development at UMass Chan Medical School. Previously, he served as CEO of LiquiGlide, an MIT spinout materials science company where he was CEO. Previously, he served as Vice President - Business Development at Lantheus Holdings, and Vice President - Finance at Siemens Healthcare Diagnostics. Dan also served as CEO of Allegro Diagnostics, a molecular diagnostics company in oncology (acquired by Veracyte) and CEO of Macrocyclics, a radiopharmaceutical company focused in oncology, CNS, and imaging (acquired by Oranomed). Earlier in his career, Dan worked in businbess development at Johnson & Johnson and Bristol-Myers Squibb. He has done deals worth an aggregate $3 billion. Dan has an M.S. from Harvard-M.I.T., an M.B.A. from Columbia Business School, and a B.A. from Macalester College.